|
The ornamental design for a transponder implanter, as shown and described. |
FIG. 1 is a perspective view showing my design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a left side elevational view thereof, the right side elevational view being a mirror image thereof;
FIG. 4 is a front elevational view thereof;
FIG. 5 is a rear elevational view thereof; and,
FIG. 6 is a bottom plan view thereof.
Patent | Priority | Assignee | Title |
10159714, | Feb 16 2011 | Intarcia Therapeutics, Inc. | Compositions, devices and methods of use thereof for the treatment of cancers |
10231923, | Sep 28 2009 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
10363287, | Feb 03 2005 | Intarcia Therapeutics, Inc. | Method of manufacturing an osmotic delivery device |
10441528, | Feb 13 2008 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
10501517, | May 16 2016 | INTARCIA THERAPEUTICS, INC | Glucagon-receptor selective polypeptides and methods of use thereof |
10527170, | Aug 09 2006 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein |
10583080, | Sep 30 2014 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
10835580, | Jan 03 2017 | INTARCIA THERAPEUTICS, INC | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
10869830, | Sep 28 2009 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
10925639, | Jun 03 2015 | INTARCIA THERAPEUTICS INC | Implant placement and removal systems |
11214607, | May 16 2016 | Intarcia Therapeutics Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
11246913, | Feb 03 2005 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
11654183, | Jan 03 2017 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of exenatide and co-administration of a drug |
11840559, | May 16 2016 | INTARCIA ASSIGNMENT FOR THE BENEFIT OF CREDITORS , LLC | Glucagon-receptor selective polypeptides and methods of use thereof |
7247160, | Dec 30 2002 | Varian Medical Systems, Inc | Apparatuses and methods for percutaneously implanting objects in patients |
9241660, | Jun 08 2005 | Senseonics, Incorporated | Insertion device and method |
9623208, | Jan 12 2004 | Varian Medical Systems, Inc | Instruments with location markers and methods for tracking instruments through anatomical passageways |
9889085, | Sep 30 2014 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
D388171, | Jun 23 1995 | Roussel Uclaf | Instrument for implantations for manual use |
D634843, | Feb 24 2009 | EDGE SURGICAL, INC | Handheld surgical depth instrument with rectangular body |
D673679, | Oct 19 2010 | Lancet | |
D761424, | Apr 16 2014 | VIACYTE, INC | Deployment tool for an encapsulation device |
D835783, | Jun 02 2016 | Intarcia Therapeutics, Inc. | Implant placement guide |
D840030, | Jun 02 2016 | INTARCIA THERAPEUTICS INC | Implant placement guide |
D860451, | Jun 02 2016 | INTARCIA THERAPEUTICS INC | Implant removal tool |
D912249, | Jun 02 2016 | Intarcia Therapeutics, Inc. | Implant removal tool |
D933219, | Jul 13 2018 | Intarcia Therapeutics, Inc. | Implant removal tool and assembly |
ER418, |
Patent | Priority | Assignee | Title |
3744493, | |||
4787384, | Oct 06 1986 | BIO MEDIC DATA SYSTEM, INC , A NJ CORP | Animal marker implanting system |
5250026, | May 27 1992 | Digital Angel Corporation | Adjustable precision transponder injector |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Dec 01 1993 | PARK, CHINSOO | BIOMEDIC DATA SYSTEMS, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 006866 | /0201 | |
Jan 18 1994 | Bio Medic Data Systems, Inc. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |